Not applicableStudy completedNCT02178475
What this trial is testing
Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
Who this might be right for
Chemotherapy-induced Febrile Neutropenia
Amgen 943